“Development Of Pretomanids And Their Therapeutic Uses In The Treatment Of Tuberculosis”. 2022. Journal of Pharmaceutical Negative Results 13 (November): 2307-13. https://doi.org/10.47750/pnr.2022.13.S05.362.